The closing price of Adicet Bio Inc (NASDAQ: ACET) was $2.24 for the day, up 1.82% from the previous closing price of $2.20. In other words, the price has increased by $+0.0400 from its previous closing price. On the day, 804980 shares were traded.
Ratios:
Our analysis of ACET’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.41 and its Current Ratio is at 8.41. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.10.
JP Morgan Downgraded its Overweight to Neutral on June 01, 2023, whereas the target price for the stock was revised from $20 to $6.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 25 ’24 when ORBIMED ADVISORS LLC bought 3,125,000 shares for $2.40 per share. The transaction valued at 7,500,000 led to the insider holds 7,526,359 shares of the business.
GORDON CARL L bought 3,125,000 shares of ACET for $7,500,000 on Jan 25 ’24. The Director now owns 7,526,359 shares after completing the transaction at $2.40 per share. On Oct 02 ’23, another insider, Schor Chen, who serves as the President & CEO of the company, bought 5,500 shares for $1.33 each. As a result, the insider paid 7,340 and bolstered with 43,469 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACET now has a Market Capitalization of 184.02M and an Enterprise Value of 45.24M. Its current Enterprise Value per Revenue stands at 2.14 whereas that against EBITDA is -0.33.
Stock Price History:
Over the past 52 weeks, ACET has reached a high of $7.50, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is 2.5811, while the 200-Day Moving Average is calculated to be 2.1936.
Shares Statistics:
ACET traded an average of 1.77M shares per day over the past three months and 1.71M shares per day over the past ten days. A total of 82.15M shares are outstanding, with a floating share count of 67.15M. Insiders hold about 18.27% of the company’s shares, while institutions hold 43.06% stake in the company. Shares short for ACET as of Feb 29, 2024 were 5.66M with a Short Ratio of 3.19, compared to 3.89M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.90% and a Short% of Float of 7.99%.
Earnings Estimates
The firm’s stock currently is rated by 5 analysts. On average, analysts expect EPS of -$0.39 for the current quarter, with a high estimate of -$0.27 and a low estimate of -$0.51, while EPS last year was -$0.72. The consensus estimate for the next quarter is -$0.35, with high estimates of -$0.27 and low estimates of -$0.39.
Analysts are recommending an EPS of between -$1.09 and -$3.05 for the fiscal current year, implying an average EPS of -$1.78. EPS for the following year is -$1.77, with 8 analysts recommending between -$1.05 and -$3.41.
